Carbios SAS Past Earnings Performance
Past criteria checks 0/6
Carbios SAS's earnings have been declining at an average annual rate of -48.5%, while the Chemicals industry saw earnings growing at 7.4% annually. Revenues have been declining at an average rate of 59.4% per year.
Key information
-48.5%
Earnings growth rate
-36.2%
EPS growth rate
| Chemicals Industry Growth | 10.4% |
| Revenue growth rate | -59.4% |
| Return on equity | -14.5% |
| Net Margin | -41,102.6% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Health Check: How Prudently Does Carbios SAS (EPA:ALCRB) Use Debt?
Apr 12
Carbios SAS (EPA:ALCRB) Has Debt But No Earnings; Should You Worry?
Jun 03Carbios SAS' (EPA:ALCRB) Robust Profit May Be Overstating Its True Earnings Potential
Apr 09Is Carbios SAS (EPA:ALCRB) Worth €39.6 Based On Its Intrinsic Value?
Jan 03
Revenue & Expenses Breakdown
How Carbios SAS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -32 | 22 | 13 |
| 31 Mar 24 | 0 | -29 | 20 | 12 |
| 31 Dec 23 | 0 | -27 | 18 | 11 |
| 30 Sep 23 | 0 | -28 | 16 | 12 |
| 30 Jun 23 | 0 | -30 | 15 | 13 |
| 31 Mar 23 | 0 | -29 | 14 | 13 |
| 31 Dec 22 | 0 | -28 | 13 | 13 |
| 30 Sep 22 | 0 | -25 | 12 | 12 |
| 30 Jun 22 | 0 | -22 | 11 | 11 |
| 31 Mar 22 | 0 | -9 | 9 | 9 |
| 31 Dec 21 | 0 | 4 | 8 | 8 |
| 30 Sep 21 | 0 | 6 | 6 | 7 |
| 30 Jun 21 | -1 | 8 | 5 | 5 |
| 31 Mar 21 | 0 | 0 | 4 | 4 |
| 31 Dec 20 | 0 | -8 | 3 | 3 |
| 30 Sep 20 | 2 | -5 | 4 | 0 |
| 30 Jun 20 | 2 | -4 | 3 | 0 |
| 31 Mar 20 | 2 | -4 | 3 | 0 |
| 31 Dec 19 | 1 | -4 | 3 | 0 |
| 30 Sep 19 | 1 | -3 | 3 | 0 |
| 30 Jun 19 | 1 | -3 | 3 | 0 |
| 31 Mar 19 | 1 | -3 | 2 | 0 |
| 31 Dec 18 | 1 | -3 | 2 | 0 |
| 30 Sep 18 | 1 | -4 | 2 | 0 |
| 30 Jun 18 | 1 | -4 | 2 | 0 |
| 31 Mar 18 | 1 | -4 | 2 | 0 |
| 31 Dec 17 | 1 | -4 | 2 | 0 |
| 30 Sep 17 | 5 | 1 | 2 | 0 |
| 30 Jun 17 | 9 | 5 | 2 | 0 |
| 31 Mar 17 | 9 | 5 | 2 | 0 |
| 31 Dec 16 | 9 | 5 | 2 | 0 |
| 30 Sep 16 | 5 | 1 | 2 | 0 |
| 30 Jun 16 | 1 | -3 | 2 | 0 |
| 31 Mar 16 | 1 | -3 | 2 | 0 |
| 31 Dec 15 | 1 | -3 | 1 | 0 |
| 30 Sep 15 | 1 | -3 | 1 | 0 |
| 30 Jun 15 | 1 | -3 | 1 | 0 |
| 31 Mar 15 | 1 | -2 | 1 | 0 |
| 31 Dec 14 | 1 | -2 | 1 | 0 |
| 30 Sep 14 | 1 | -2 | 1 | 0 |
| 30 Jun 14 | 1 | -2 | 1 | 0 |
| 31 Mar 14 | 1 | -2 | 1 | 0 |
| 31 Dec 13 | 1 | -2 | 1 | 0 |
Quality Earnings: ALCRB is currently unprofitable.
Growing Profit Margin: ALCRB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ALCRB is unprofitable, and losses have increased over the past 5 years at a rate of 48.5% per year.
Accelerating Growth: Unable to compare ALCRB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ALCRB is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-8.2%).
Return on Equity
High ROE: ALCRB has a negative Return on Equity (-14.55%), as it is currently unprofitable.